You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

transformation to acute myeloid leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Analyze Occurrence of Transformation From Myelodysplastic

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
    • Kobe, Hyogo, Japan
      Shinko Hospital
    Jun 13, 2022

    Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

    Recruiting
    • Leukemia
    • +12 more
    • filgrastim
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 20, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Acute Myeloid Leukemia Trial in Antalya

    Recruiting
    • Acute Myeloid Leukemia
      • Antalya, Turkey
        Antalya Training and Research Hospital
      Jul 29, 2023

      Acute Myeloid Leukemia Trial (Dasatinib)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Sep 20, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      Patients With Acute Myeloid Leukemia

      Recruiting
      • Acute Myeloid Leukemia, Adult
        • Freiburg, CA, Germany
          Medical Center- University of Freiburg
        Aug 4, 2023

        Frequency and Risk Factors of Acute Myeloid Leukemia

        Not yet recruiting
        • Myeloid Leukemia
        • Bone marrow aspirite for diagnosis
        • (no location specified)
        Mar 15, 2023

        Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • CD123 targeted CAR-NK cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Aug 28, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

        Recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Peking University People's Hospital
        Jun 23, 2023

        Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Lyon, France
          Centre Léon Bérard
        Nov 30, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • (no location specified)
        May 29, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 1, 2023

        Acute Myeloid Leukemia Trial (ABBV-787)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 29, 2023

        Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Oral azacitidine
        • Seoul, Korea, Republic of
          Bristol-Myers Squibb YH
        Oct 3, 2023

        Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

        Active, not recruiting
        • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
        • +9 more
        • Sewell, New Jersey
        • +4 more
        Dec 13, 2022

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • Hetrombopag Olamine
        • (no location specified)
        Jul 5, 2023

        Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

        Not yet recruiting
        • Acute Myeloid Leukemia, in Relapse
        • Acute Myeloid Leukemia Refractory
        • (no location specified)
        Nov 9, 2023

        Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Yuan Kong
        Sep 4, 2023

        PET Tracer Based FDG Signal for Predicting Prognosis in Acute

        Enrolling by invitation
        • Acute Myeloid Leukemia
        • No intervention
        • Guangzhou, Guangdong, China
          First Affiliated Hospital of Jinan University
        Jun 22, 2023

        Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

        Not yet recruiting
        • Acute Myeloid Leukemia, in Relapse
        • +2 more
        • CPI 613
        • +3 more
        • Winston-Salem, North Carolina
          Wake Forest Baptist Comprehensive Cancer Center
        May 10, 2023

        A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

        Not yet recruiting
        • C-KIT Mutation
          • (no location specified)
          Nov 2, 2023

          Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

          Recruiting
          • Refractory/Relapse Acute Myeloid Leukemia
          • Kunming, Yunnan, China
            Department of Hematology,920th Hospital of Joint Logistic Suppor
          Mar 28, 2023